Company
Peptivo
Peptivo publishes oral semaglutide and compounded tirzepatide, from $249 to $299 a month.
- 2 programs
- 2 molecules
- 2 readings
Read from peptivo.com on September 2, 2026. This page records what the company publishes. It is not a review and takes no position on the company.
Go to Peptivo
We earn nothing from this link. Peptivo has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
What it costs
first month, including the required fees on record · Semaglutide Oral+, starting price
first month, including the required fees on record · Tirzepatide Oral, starting price
Terms
| States | All 50 states |
|---|
Not yet checked: pharmacy, membership and consultation fee.
Terms can differ between this company’s programs; each entry carries its own.
Programs
Notes
Recorded against this company rather than one program.
September 2, 2026
- 1. 'No Hidden Fees. No Membership Cost' is stated repeatedly, and the per-day medication prices appear to be all-inclusive, so no separate membership entry was recorded. The 'Tirzepatide Oral' SKU has no matching enum ('oral tirzepatide' doesn't exist on this register); recorded as compounded tirzepatide since the page tags it COMPOUNDED. Semaglutide Oral+ and both injections don't state vial vs. pen or tablet vs. sublingual, so form is not-disclosed throughout.
Before you act
Cite this
Treatment Registry. (2026). Peptivo: recorded programs and prices. Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/peptivo